DR. MARTIN BRENNER
Equibles does not estimate personal net worth.
Get an email with a short summary when iBio, Inc. publishes a filing, an earnings call transcript or a press release.
Get IBIO alertsAbout DR. MARTIN BRENNER
DR. MARTIN BRENNER is recorded as Board Member at iBio, Inc. (IBIO) since January 1, 2024 and CEO at iBio, Inc. (IBIO) since June 22, 2023. The newest filing on record that lists DR. MARTIN BRENNER as Board Member at iBio, Inc. (IBIO) is dated September 4, 2026. iBio, Inc. reported in an 8-K filed June 27, 2023 that DR. MARTIN BRENNER was appointed Chief Executive Officer, effective June 22, 2023. iBio, Inc. reported in an 8-K filed January 25, 2023 that DR. MARTIN BRENNER was appointed Interim Chief Executive Officer, effective January 20, 2023. The proxy statement of iBio, Inc. reports total compensation of $1,014,282 for DR. MARTIN BRENNER in fiscal 2021, including a base salary of $177,955. Disclosed compensation is on record for 2 fiscal years. iBio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at iBio, Inc. includes Thomas F. Isett 3rd (CEO and Chairman), Chip Clark (Chairman), Felipe Duran (CFO) and 7 others.
“On June 22, 2023, the Board of Directors (the “Board”) of iBio, Inc., a Delaware corporation (the “Company”), appointed Dr. Martin Brenner its then Interim Chief Executive Officer (CEO), to the position of permanent CEO effective immediately, and Mr. Felipe Duran, its then Interim Chief Financial Officer (CFO), to the position of permanent CFO effective immediately.”
“On January 20, 2023, the Board of Directors (the "Board") of iBio, Inc., a Delaware corporation (the "Company"), appointed Dr. Martin Brenner to the position of Interim Chief Executive Officer, effective immediately, and Mr. Felipe Duran, to the position of Interim Chief Financial Officer, effective as of February 13, 2023.”
Affiliation history
-
Current
2024-01-01–present
Last confirmed September 4, 2026
-
Current
2023-06-22–present
-
iBio, Inc. (IBIO)
Proxy statement
CurrentStart not stated–present
Last confirmed October 26, 2021
Company network
Leadership on record at iBio, Inc.
- Thomas F. Isett 3rd CEO, Chairman
- Chip Clark Chairman
- Felipe Duran CFO
- Robert M. Lutz CFO
- Randy J. Maddux COO
- John Delta Chief Accounting Officer
- ANT ó NIO PARADA Board Member
- DR. ALEXANDRA KROPOTOVA Board Member
- David Arkowitz Board Member
- Dr. Elizabeth Stoner Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | iBio, Inc. (IBIO) | Chief Scientific Officer | $177,955 | $1,014,282 |
| 2020 | iBio, Inc. (IBIO) | Chief Scientific Officer | — | — |